NLVP
New Leaf Venture Partners Portfolio holdings
AUM
$52.9M
This Quarter Return
+6.74%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$140M
AUM Growth
+$140M
(+0.51%)
Cap. Flow
+$6.95M
Cap. Flow
% of AUM
4.98%
Top 10 Holdings %
Top 10 Hldgs %
97.21%
Holding
16
New
2
Increased
2
Reduced
5
Closed
1
Top Buys
| 1 |
CRISPR Therapeutics
CRSP
|
$11.9M |
| 2 |
EVAR
Lombard Medical, Inc.
EVAR
|
$643K |
| 3 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$90.5K |
| 4 |
Rocket Pharmaceuticals
RCKT
|
$73.2K |
Top Sells
| 1 |
Wave Life Sciences
WVE
|
$3.29M |
| 2 |
SAGE
Sage Therapeutics
SAGE
|
$947K |
| 3 |
Dynavax Technologies
DVAX
|
$569K |
| 4 |
DERM
Dermira, Inc.
DERM
|
$488K |
| 5 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$388K |
Sector Composition
| 1 | Healthcare | 95.28% |
